DESIGN OF EXTENDED RELEASE MATRIX TABLET OF TRAMADOL HYDROCHLORIDE USING COMBINATION OF HYDROPHOBIC AND HYDROPHILIC POLYMER
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2017, Vol 9, Issue 5
Abstract
The aim of design of oral extended drug delivery system is to achieve a prolonged therapeutic effect by continuously releasing medicament over an extended period of time after administration of a single dose. An attempt was made to formulate Tramadol Extended Release (ER) matrix tablet using combination of hydrophobic and hydrophilic polymer consisting of ethyl cellulose, HPMC K15M, carbopol, and xanthan gum. The polymeric concentration of hydrophobic and hydrophilic polymer was optimized and was found that drug to polymeric ratio (hydrophobic and hydrophilic) of 1:0.75:0.75 was appropriate for the formulation of Tramadol ER tablet. The concentration of hydrophobic polymer was kept constant were as the combination of hydrophilic polymer was attempted and combined to hydrophobic polymer to retard the drug release for 24-hour from the matrix tablet. A total of nine formulations (F1-F9) of Tramadol matrix tablet, with different concentration of hydrophobic and hydrophilic polymer were used with other excipients. The tablets were compressed by direct compression method after subjecting the blend to blend physical parameters studies like studies like angle of repose, bulk density, tapped density, Carr’s index. The results obtained were satisfactory. Post compression parameters like hardness, weight variation, friability, drug content analysis and in-vitro release profiles of drug from all the formulations could be best expressed by Higuchi’s equation, as the plots showed high linearity (R2: 0.942-0.995). To confirm the diffusion mechanism, the data were fit into Korsmeyer equation. The formulations F-1 to F-6 showed good linearity (R2: 0.961 to 0.993), which indicate the mechanism is diffusion coupled with erosion.
Authors and Affiliations
Sunil Kumar Shah, Prabhakar Bhudholiya, Supriya Pandey, Sujata Kushwaha, Firoz Khan
Keywords
Related Articles
- EP ID EP618307
- DOI 10.25004/IJPSDR.2017.090502
- Views 104
- Downloads 0
BLOCKADE OF EPIDERMAL GROWTH FACTOR RECEPTOR, CYCLOXYGENASE-2 (COX-2) AND MAMMALIAN TARGET OF RAPAMYCIN (M-TOR) IN ANIMAL MODEL OF LUNG CANCER
To explore the effectiveness and possible toxicity of the use of epidermal growth factor receptor inhibitor (EGFR Inhibitor), Celecoxib (COX2 inhibitor) and Sirolimus (m-TOR inhibitor) as single agents and drug combinati...
FORMULATION AND CHARACTERIZATION OF FAST DISINTEGRATING TABLET OF ACECLOFENAC BY USING SUBLIMATION METHOD
In the present work, fast disintegrating tablets of Aceclofenac were prepared by subliming method with a view to enhance patient compliance. In this paper, two super-disintegrants, viz., crospovidone and sodium starch gl...
ROLE OF WITHANIA SOMNIFERA IN PREVENTION AND TREATMENT OF CANCER: AN OVERVIEW
Cancer is hyperproliferative disorder that involves transformation, dysregulation of apoptosis, proliferation, invasion, angiogenesis and metastasis. Millions of people die every year with different types of cancer such...
Ocular Tolerability and Efficacy of Ebastine Colloidal Formulation in Allergic Conjunctivitis
Allergic conjunctivitis (AC), defined by ocular itching, hyperemia, lacrimation and edema, impairs the quality of life across the globe. Ebastine is available as an oral antihistamine formula, such as tablets and syrup,...
SUBSTITUTED THIAZOLE LINKED MURRAYANINE-SCHIFF’S BASE DERIVATIVES AS POTENTIAL ANTI-BREAST CANCER CANDIDATES: FUTURE EGFR KINASE INHIBITORS
Cancer is the second leading causes of mortality across the planet which has had affected millions. In spite of massive efforts in producing new molecules and chemotherapeutic approaches for managing cancer, it continued...